These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31787542)

  • 1. Sex Differences in Urothelial Bladder Cancer Survival.
    Radkiewicz C; Edgren G; Johansson ALV; Jahnson S; Häggström C; Akre O; Lambe M; Dickman PW
    Clin Genitourin Cancer; 2020 Feb; 18(1):26-34.e6. PubMed ID: 31787542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bladder cancer survival: Women only fare worse in the first two years after diagnosis.
    Richters A; Dickman PW; Witjes JA; Boormans JL; Kiemeney LALM; Aben KKH
    Urol Oncol; 2019 Dec; 37(12):853-861. PubMed ID: 31481299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic and clinicopathologic value of ki-67 and profilin 1 immunohistochemical expression in primary pT1 urothelial bladder cancer.
    Culpan M; Turan T; Ozkanli SS; Zenginkinet T; Kazan O; Ucar T; Atis G; Caskurlu T; Yildirim A
    J Cancer Res Ther; 2021; 17(2):434-442. PubMed ID: 34121689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bladder cancer survival: Women better off in the long run.
    Andreassen BK; Grimsrud TK; Haug ES
    Eur J Cancer; 2018 May; 95():52-58. PubMed ID: 29635144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing Rates of Perioperative Chemotherapy are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion.
    Rosiello G; Knipper S; Palumbo C; Pecoraro A; Luzzago S; Deuker M; Tian Z; Gandaglia G; Gallina A; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
    Clin Genitourin Cancer; 2020 Feb; 18(1):35-44.e1. PubMed ID: 31711842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Swedish National Registry of Urinary Bladder Cancer: No difference in relative survival over time despite more aggressive treatment.
    Jahnson S; Hosseini Aliabad A; Holmäng S; Jancke G; Liedberg F; Ljungberg B; Malmström PU; Rosell J
    Scand J Urol; 2016; 50(1):14-20. PubMed ID: 26382667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary rates of pathological features and mortality for adenocarcinoma of the urinary bladder in the USA.
    Zaffuto E; Gazdovich S; Leyh-Bannurah SR; Huland H; Abdollah F; Shariat SF; Menon M; Briganti A; Montorsi F; Karakiewicz PI
    Int J Urol; 2017 Feb; 24(2):117-123. PubMed ID: 27875858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Adjuvant Intravesical Bacillus Calmette-Guérin Treatment on Patients with High-Grade T1 Bladder Cancer.
    Novotny V; Froehner M; Ollig J; Koch R; Zastrow S; Wirth MP
    Urol Int; 2016; 96(2):136-41. PubMed ID: 26789626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?
    Berg S; D'Andrea D; Vetterlein MW; Cole AP; Fletcher SA; Krimphove MJ; Marchese M; Lipsitz SR; Sonpavde G; Noldus J; Shariat SF; Kibel AS; Trinh QD; Mossanen M
    Cancer; 2019 May; 125(9):1449-1458. PubMed ID: 30620387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of the effect of prostatic invasion patterns on cancer-specific mortality after radical cystectomy in pT4a urothelial carcinoma of the bladder.
    Vallo S; Gilfrich C; Burger M; Volkmer B; Boehm K; Rink M; Chun FK; Roghmann F; Novotny V; Mani J; Brisuda A; Mayr R; Stredele R; Noldus J; Schnabel M; May M; Fritsche HM; Pycha A; Martini T; Wirth M; Roigas J; Bastian PJ; Nuhn P; Dahlem R; Haferkamp A; Fisch M; Aziz A
    Urol Oncol; 2016 Oct; 34(10):432.e1-8. PubMed ID: 27283218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Location May Predict Adverse Pathology and Survival Following Definitive Treatment for Bladder Cancer: A National Cohort Study.
    Weiner AB; Desai AS; Meeks JJ
    Eur Urol Oncol; 2019 May; 2(3):304-310. PubMed ID: 31200845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognosis in pT3b infiltrating tumors of the bladder treated by adjuvant chemotherapy].
    Sahwi A; Robert M; Delbos O; Legouffe E; Guiter J; Navratil H
    Prog Urol; 1998 Dec; 8(6):1007-11. PubMed ID: 9894259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender-related differences in urothelial carcinoma of the bladder: a population-based study from the Swedish National Registry of Urinary Bladder Cancer.
    Thorstenson A; Hagberg O; Ljungberg B; Liedberg F; Jancke G; Holmäng S; Malmström PU; Hosseini A; Jahnson S
    Scand J Urol; 2016 Aug; 50(4):292-7. PubMed ID: 27002743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of early stage small cell bladder cancer is not always dismal.
    Lim JH; Sundar S
    ESMO Open; 2019; 4(6):e000559. PubMed ID: 31798978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a.
    May M; Bastian PJ; Brookman-May S; Fritsche HM; Tilki D; Otto W; Bolenz C; Gilfrich C; Trojan L; Herrmann E; Moritz R; Tiemann A; Müller SC; Ellinger J; Buchner A; Stief CG; Wieland WF; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Nuhn P; Burger M
    Urol Oncol; 2013 Oct; 31(7):1141-7. PubMed ID: 22056404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle-invasive transitional cell carcinoma of the urinary bladder: a population-based study of patterns of care and prognostic factors.
    Scrimger RA; Murtha AD; Parliament MB; Venner PM; Hanson J; Houle G; Chetner M
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):23-30. PubMed ID: 11516847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder.
    Palumbo C; Mistretta FA; Knipper S; Pecoraro A; Tian Z; Shariat SF; Saad F; Simeone C; Briganti A; Antonelli A; Karakiewicz PI
    Urol Oncol; 2019 Dec; 37(12):893-899. PubMed ID: 31296422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.
    Wankowicz SAM; Werner L; Orsola A; Novak J; Bowden M; Choueiri TK; de Torres I; Morote J; Freeman GJ; Signoretti S; Bellmunt J
    J Urol; 2017 Oct; 198(4):817-823. PubMed ID: 28487100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.